PROSPECTS FOR THE CREATION OF IMPORT-SUBSTITUTING ANTIDIABETIC MEDICINES IN UZBEKISTAN

Abstract

The growing burden of diabetes mellitus in Uzbekistan has created an urgent need for expanding domestic pharmaceutical production of antidiabetic medicines. The dependence on imported drugs increases treatment costs and creates challenges related to supply stability and accessibility for patients. The present article evaluates scientific, technological, and economic prospects for the development of import-substituting antidiabetic medicines in Uzbekistan. Special attention is devoted to pharmaceutical manufacturing capacities, development of local active pharmaceutical ingredients, use of medicinal plant resources, and implementation of innovative dosage technologies. The study demonstrates that strengthening domestic pharmaceutical production may contribute to improving national healthcare sustainability and reducing external pharmaceutical dependency.